Single-domain antibody-based protein degrader for synucleinopathies
Abstract Synucleinopathies are a group of neurodegenerative diseases characterized by the accumulation of α-synuclein (α-syn) in the brain, leading to motor and neuropsychiatric symptoms. Currently, there are no known cures for synucleinopathies, and treatments mainly focus on symptom management. In...
| Huvudupphovsmän: | , , , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
BMC
2024-05-01
|
| Serie: | Molecular Neurodegeneration |
| Länkar: | https://doi.org/10.1186/s13024-024-00730-y |